Profil Financier
Dennis Bastas occupe actuellement le rang #1150 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $3.7 B (+$335 sur 24h).
Dennis Bastas is chairman and group CEO of Australia-based diversified health and beauty company DBG Health.
Bastas was born to Greek parents who migrated to Melbourne in 1960s.
He began his career in logistics at retailing giant Coles Myer. In the early 2000s he founded Genepharm Australasia, which he later sold to Watson in 2012 for $252 million.
In 2023, Bastas' DBG Health acquired three companies including Arrotex Pharmaceuticals, the country's largest pharmaceutical company by market share, for $671 million.
In 2025, Bastas sold a stake in DBG Global Enterprises, the holding company of DBG Health, to global merchant bank BDT & MSD Partners for $1 billion, valuing the company at more than $4.7 billion.